According to China's COVID-19 Diagnosis and Treatment Protocol (Trial Version 9) [16], the criteria for discharge from the FSH were: negative nucleic acid tests for COVID-19 two consecutive times (with an interval of at least 24 h between samples), normal body temperature for at least 3 days, and obvious remission of respiratory tract and other clinical symptoms. The gene discussed is BRD2; the disease is COVID-19.